✉news ScienceBiology first seen 11 h ago, last 50 min ago, peak #1
Lunit and Summit Therapeutics Partner on AI Pathology for Tumour Biology
Original: Lunit and Summit Therapeutics Join Forces to Decode Tumour Biology with AI-Powered Pathology
Medical AI company Lunit and biopharmaceutical firm Summit Therapeutics have announced a partnership to analyse tumour biology using AI-powered pathology tools. The collaboration will apply Lunit's digital pathology technology to help characterise cancers and support drug development research. Details on financial terms and specific programmes have not been disclosed in the initial announcement.
Why now: The deal pairs a leading oncology drug developer with an AI diagnostics firm, reflecting growing interest in AI-driven cancer research partnerships.
Evidence
- Lunit and Summit Therapeutics Join Forces to Decode Tumour Biology with AI-Powered Pathology · BioPharma APAC
API: https://socialmediatrends-api.osmike.com/v1/trends/3649284